Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: The Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial

American Heart Journal

Volumn 159, Issue 6, 2010, Pages

  Abraham, William T ^a   Gras, Daniel ^b   Yu, Cheuk Man ^c   Guzzo, Lisa ^d   Gupta, Manish S ^e  

^a OHIO STATE UNIVERSITY   (United States)

^b Nouvelles Cliniques Nantaises   (France)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d St Jude Medical   (Belgium)

^e ST JUDE MEDICAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; PATIENT CARE; PATIENT SAFETY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RANDOMIZED CONTROLLED TRIAL; STANDARD; THERAPY DELAY; TREATMENT INDICATION;

EID: 77952983318     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.02.034     Document Type: Article

References (21)

1. Cazeau S., Leclercq C., Lavergne T., et al. Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344 (2001) 873-880
2. Abraham W.T., Fisher W.G., Smith A.L., et al., MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
3. Cleland J.G., Daubert J.C., Erdmann E., et al., Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
4. Sawhney N.S., Waggoner A.D., Garhwal S., et al. Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. Heart Rhythm 1 (2004) 562-567
5. O'Donnell D., Nadurata V., Hamer A., et al. Long-term variations in optimal programming of cardiac resynchronization therapy devices. Pacing Clin Electrophysiol 28 Suppl 1 (2005) S24-S26
6. Porciani M.C., Dondina C., Macioce R., et al. Temporal variation in optimal atrioventricular and interventricular delay during cardiac resynchronization therapy. J Card Fail 12 (2006) 715-719
7. Valzania C., Biffi M., Martignani C., et al. Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. Echocardiography 24 (2007) 933-939
8. Porciani M.C., Rao C.M., Mochi M., et al. A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy. Pacing Clin Electrophysiol 31 (2008) 56-63
9. Min X., Meine M., Baker II J.H., et al. Estimation of the optimal VV delay by an IEGM-based method in cardiac resynchronization therapy. Pacing Clin Electrophysiol 30 Suppl 1 (2007) S19-S22
10. Baker II J.H., McKenzie III J., Beau S., et al. Acute evaluation of programmer-guided AV/PV and VV delay optimization comparing an IEGM method and echocardiogram for cardiac resynchronization therapy in heart failure patients and dual-chamber ICDs implants. J Cardiovasc Electrophysiol 18 (2007) 185-191
11. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 7 (2001) 176-182
12. Young J.B., Abraham W.T., Smith A.L., et al., Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA. 289 (2003) 2685-2694
13. Abraham W.T., Young J.B., León A.R., et al., Multicenter InSync ICD II Study Group. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation. 110 (2004) 2864-2868
14. Morales M.A., Startari U., Panchetti L., et al. Atrioventricular delay optimization by Doppler-derived left ventricular dP/dt improves 6-month outcome of resynchronized patients. Pacing Clin Electrophysiol 29 (2006) 564-568
15. Gras D., Gupta M.S., Boulogne E., et al. Optimization of AV and VV delays in the real world CRT patient population: results of an International Survey on Current Clinical Practice (in print). PACE (2009)
16. Perego G.B., Chianca R., Facchini M., et al. Simultaneous vs. sequential biventricular pacing in dilated cardiomyopathy: an acute hemodynamic study. Eur J Heart Fail 5 (2003) 305-313
17. Van Gelder B., Bracke F., Mejer A., et al. Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy. Am J Cardiol 93 (2004) 1500-1503
18. Sogaard P., Egeblad H., Pedersen A.K., et al. Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging. Circulation 106 (2002) 2078-2084
19. Porciani M.C., Dondina C., Macioce R., et al. Echocardiographic examination of atrioventricular and interventricular delay optimization in cardiac resynchronization therapy. Am J Cardiol 95 (2005) 1108-1110
20. Bax J.J., Abraham T., Barold S.S., et al. Cardiac resynchronization therapy: part 1-issues before device implantation. J Am Coll Cardiol 46 (2005) 2153-2167
21. Bax J.J., Abraham T., Barold S.S., et al. Cardiac resynchronization therapy: part 2-issues during and after device implantation and unresolved questions. J Am Coll Cardiol 46 (2005) 2168-2182